Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neurodegenerative Disease Research Peptides α-Synuclein (61–95), Human | NAC Aggregation Peptide

DESCRIPTION

α-Synuclein (61–95) is a 35-amino-acid fragment corresponding to the central non-Aβ component (NAC) region of human α-synuclein. This hydrophobic region plays an important role in α-synuclein self-association and contains sequence elements that contribute to β-sheet-rich oligomer and fibril formation.

The historical term NAC arose from early studies of Alzheimer-associated amyloid material. Today, this sequence is more appropriately positioned within α-synuclein aggregation, Parkinson’s disease, Lewy body and protein-misfolding research. The NAC sequence corresponds to residues 61–95 of α-synuclein.

Product Information

PropertySpecification
Product Nameα-Synuclein (61–95), Human
SynonymNAC Peptide
SequenceEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFV
Length35 amino acids
Molecular FormulaC141H235N39O49
Theoretical MW~3260.65 Da
OriginHuman α-synuclein residues 61–95
Peptide TypeAggregation-prone synuclein fragment
Research Focusα-Synuclein aggregation, fibrillation, Parkinson’s disease, protein misfolding
PurityFrom crude to 98%

Why the NAC Region Is Experimentally Useful

Full-length α-synuclein contains 140 residues and exhibits complex conformational behavior. Studying the isolated NAC region allows researchers to focus on one of the principal aggregation-prone segments without introducing the complete protein.

Synthetic NAC peptide can be used in fibrillation studies, cross-seeding experiments, peptide–membrane interaction assays and structure–activity studies examining residues involved in self-association.

Sample Preparation Matters

Aggregation state can vary substantially with solvent history, concentration, ionic strength, temperature and incubation time.

For quantitative comparisons, We recommend keeping sample preparation consistent across peptide lots and analogs rather than treating nominal HPLC purity as the only experimental variable.

Custom NAC variants, labeled derivatives and residue substitutions can be evaluated through Custom Peptide Synthesis. Analytical identity and purity can be supported through Peptide Quality Control.

Frequently Asked Questions

What is the NAC region of α-synuclein?

The NAC region is a hydrophobic segment within human α-synuclein that contributes strongly to peptide self-association and fibril formation. The commonly studied NAC fragment corresponds to α-synuclein residues 61–95 and contains 35 amino acids.

Why is α-synuclein (61–95) used in aggregation research?

The isolated NAC sequence allows researchers to study one of the principal aggregation-prone regions of α-synuclein without using the full 140-amino-acid protein. It is useful for investigating fibril nucleation, amyloid assembly, cross-seeding, membrane interactions, and sequence-specific aggregation mechanisms.

Is NAC an amyloid-β peptide?

No. The historical name “non-Aβ component” came from its early identification in amyloid preparations, but NAC is derived from α-synuclein, not amyloid-β precursor protein. It should therefore be distinguished clearly from Aβ40, Aβ42, and other APP-derived amyloid peptides.

Is α-synuclein (61–95) mainly relevant to Alzheimer’s or Parkinson’s research?

Although the NAC terminology originated in Alzheimer-associated amyloid studies, current research relevance is much stronger in α-synuclein aggregation, Parkinson’s disease, Lewy body biology, and synucleinopathies.

Research Use Only.

α-Synuclein (61–95), Human | NAC Aggregation Peptide

Catalog No: AS2713

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit